[-] Show simple item record

dc.contributor.advisorMiddleton, John R.eng
dc.contributor.authorHoernig, Kenton J. (Kenton John)eng
dc.date.issued2013eng
dc.date.submitted2013 Falleng
dc.description"December 2013."eng
dc.description"A Thesis Presentation to the Faculty of the Graduate School, University of Missouri--Columbia In Partial Fulfillment of the Requirements for the Degree (Master of Science)."eng
dc.descriptionThesis supervisor: Dr. John R. Middleton.eng
dc.description.abstract[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] This study evaluated the efficacy of a lysostaphin-fusion protein (Lyso-PTD) as a dry-cow therapy for the treatment of experimentally-induced chronic, subclinical Staphylococcus aureus mastitis. Twenty-two Holstein dairy cows were experimentally infected with Staph aureus in a single pair of diagonal mammary quarters approximately 45 d before dry-off. Staphylococcus aureus infected mammary quarters of cows were randomly assigned to one of two groups at dry-off 1) 279 mg of Lyso-PTD in 50 mL of vehicle (n = 11 cows; 22 quarters) or 2) 50 mL of vehicle solution (n =11 cows; 22 quarters) by intramammary infusions. All cows were followed for 30 d post-partum to determine cure rates using bacteriologic culture, somatic cell counts, and clinical mastitis scores. No cures were recorded in either the treatment or control groups. Milk somatic cell count, bacterial colony counts, and mastitis scores did not significantly differ between groups (P = 0.832, P = 0.117, and P= 0.108, respectively). Follow-up studies in lactating cows revealed neither increasing the Lyso-PTD dose to 1340mg nor treatment with cephapirin sodium showed improved efficacy. In conclusion, Lyso-PTD was not an effective dry-cow therapeutic for chronic, subclinical Staph. aureus mastitis at the experimental dose and formulation used.eng
dc.description.bibrefIncludes bibliographical references (pages 57-74).eng
dc.format.extent1 online resource (vii, 80 pages) : illustrationseng
dc.identifier.oclc900087118eng
dc.identifier.urihttps://hdl.handle.net/10355/44735
dc.identifier.urihttps://doi.org/10.32469/10355/44735eng
dc.languageEnglisheng
dc.publisherUniversity of Missouri--Columbiaeng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. Graduate School. Theses and Dissertationseng
dc.rightsAccess is limited to the campuses of the University of Missouri.eng
dc.sourceSubmitted by University of Missouri--Columbia Graduate School.eng
dc.titleThe use of a lysostaphin fusion protein as a dry-cow treatment for chronic Staphylococcus aureua mastitis in dairy cattleeng
dc.typeThesiseng
thesis.degree.disciplineVeterinary biomedical sciences (MU)eng
thesis.degree.grantorUniversity of Missouri--Columbiaeng
thesis.degree.levelMasterseng
thesis.degree.nameM.S.eng


Files in this item

[PDF]
[PDF]
[PDF]

This item appears in the following Collection(s)

[-] Show simple item record